174 related articles for article (PubMed ID: 36719907)
1. Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.
Turtle L; Thorpe M; Drake TM; Swets M; Palmieri C; Russell CD; Ho A; Aston S; Wootton DG; Richter A; de Silva TI; Hardwick HE; Leeming G; Law A; Openshaw PJM; Harrison EM; ; Baillie JK; Semple MG; Docherty AB
PLoS Med; 2023 Jan; 20(1):e1004086. PubMed ID: 36719907
[TBL] [Abstract][Full Text] [Related]
2. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
Docherty AB; Harrison EM; Green CA; Hardwick HE; Pius R; Norman L; Holden KA; Read JM; Dondelinger F; Carson G; Merson L; Lee J; Plotkin D; Sigfrid L; Halpin S; Jackson C; Gamble C; Horby PW; Nguyen-Van-Tam JS; Ho A; Russell CD; Dunning J; Openshaw PJ; Baillie JK; Semple MG;
BMJ; 2020 May; 369():m1985. PubMed ID: 32444460
[TBL] [Abstract][Full Text] [Related]
3. Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study.
Turtle L; Elliot S; Drake TM; Thorpe M; Khoury EG; Greenhalf W; Hardwick HE; Leeming G; Law A; Oosthuyzen W; Pius R; Shaw CA; Baillie JK; Openshaw PJM; Docherty AB; Semple MG; Harrison EM; Palmieri C;
Lancet Oncol; 2024 May; 25(5):636-648. PubMed ID: 38621404
[TBL] [Abstract][Full Text] [Related]
4. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.
Docherty AB; Mulholland RH; Lone NI; Cheyne CP; De Angelis D; Diaz-Ordaz K; Donegan C; Drake TM; Dunning J; Funk S; García-Fiñana M; Girvan M; Hardwick HE; Harrison J; Ho A; Hughes DM; Keogh RH; Kirwan PD; Leeming G; Nguyen Van-Tam JS; Pius R; Russell CD; Spencer RG; Tom BD; Turtle L; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
Lancet Respir Med; 2021 Jul; 9(7):773-785. PubMed ID: 34000238
[TBL] [Abstract][Full Text] [Related]
5. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
[TBL] [Abstract][Full Text] [Related]
6. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Russell CD; Fairfield CJ; Drake TM; Turtle L; Seaton RA; Wootton DG; Sigfrid L; Harrison EM; Docherty AB; de Silva TI; Egan C; Pius R; Hardwick HE; Merson L; Girvan M; Dunning J; Nguyen-Van-Tam JS; Openshaw PJM; Baillie JK; Semple MG; Ho A;
Lancet Microbe; 2021 Aug; 2(8):e354-e365. PubMed ID: 34100002
[TBL] [Abstract][Full Text] [Related]
7. Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
Wainstein M; MacDonald S; Fryer D; Young K; Balan V; Begum H; Burrell A; Citarella BW; Cobb JP; Kelly S; Kennon K; Lee J; Merson L; Murthy S; Nichol A; Semple MG; Strudwick S; Webb SA; Rossignol P; Claure-Del Granado R; Shrapnel S;
PLoS Med; 2022 Apr; 19(4):e1003969. PubMed ID: 35442972
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.
Knight SR; Ho A; Pius R; Buchan I; Carson G; Drake TM; Dunning J; Fairfield CJ; Gamble C; Green CA; Gupta R; Halpin S; Hardwick HE; Holden KA; Horby PW; Jackson C; Mclean KA; Merson L; Nguyen-Van-Tam JS; Norman L; Noursadeghi M; Olliaro PL; Pritchard MG; Russell CD; Shaw CA; Sheikh A; Solomon T; Sudlow C; Swann OV; Turtle LC; Openshaw PJ; Baillie JK; Semple MG; Docherty AB; Harrison EM;
BMJ; 2020 Sep; 370():m3339. PubMed ID: 32907855
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
Drake TM; Riad AM; Fairfield CJ; Egan C; Knight SR; Pius R; Hardwick HE; Norman L; Shaw CA; McLean KA; Thompson AAR; Ho A; Swann OV; Sullivan M; Soares F; Holden KA; Merson L; Plotkin D; Sigfrid L; de Silva TI; Girvan M; Jackson C; Russell CD; Dunning J; Solomon T; Carson G; Olliaro P; Nguyen-Van-Tam JS; Turtle L; Docherty AB; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
Lancet; 2021 Jul; 398(10296):223-237. PubMed ID: 34274064
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
Martin CA; Pan D; Melbourne C; Teece L; Aujayeb A; Baggaley RF; Bryant L; Carr S; Gregary B; Gupta A; Guyatt AL; John C; McManus IC; Nazareth J; Nellums LB; Reza R; Simpson S; Tobin MD; Woolf K; Zingwe S; Khunti K; Abrams KR; Gray LJ; Pareek M;
PLoS Med; 2022 May; 19(5):e1004015. PubMed ID: 35617423
[TBL] [Abstract][Full Text] [Related]
11. Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort.
Yates T; Zaccardi F; Islam N; Razieh C; Gillies CL; Lawson CA; Chudasama Y; Rowlands A; Davies MJ; Docherty AB; Openshaw PJM; Baillie JK; Semple MG; Khunti K
BMC Infect Dis; 2021 Jul; 21(1):717. PubMed ID: 34330226
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study.
Geretti AM; Stockdale AJ; Kelly SH; Cevik M; Collins S; Waters L; Villa G; Docherty A; Harrison EM; Turtle L; Openshaw PJM; Baillie JK; Sabin CA; Semple MG
Clin Infect Dis; 2021 Oct; 73(7):e2095-e2106. PubMed ID: 33095853
[TBL] [Abstract][Full Text] [Related]
13. Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol.
Knight SR; Gupta RK; Ho A; Pius R; Buchan I; Carson G; Drake TM; Dunning J; Fairfield CJ; Gamble C; Green CA; Halpin S; Hardwick HE; Holden KA; Horby PW; Jackson C; Mclean KA; Merson L; Nguyen-Van-Tam JS; Norman L; Olliaro PL; Pritchard MG; Russell CD; Shaw CA; Sheikh A; Solomon T; Sudlow C; Swann OV; Turtle LCW; Openshaw PJM; Baillie JK; Docherty A; Semple MG; Noursadeghi M; Harrison EM; ;
Thorax; 2022 Jun; 77(6):606-615. PubMed ID: 34810237
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients.
Lee JE; Kim J; Hwang M; Kim YH; Chung MJ; Jeong WG; Jeong YJ
Korean J Radiol; 2024 May; 25(5):481-492. PubMed ID: 38627873
[TBL] [Abstract][Full Text] [Related]
15. Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System.
Tartof SY; Slezak JM; Puzniak L; Hong V; Frankland TB; Xie F; Ackerson BK; Takhar H; Ogun OA; Simmons S; Zamparo JM; Tseng HF; Jodar L; McLaughlin JM
JAMA Netw Open; 2023 Jan; 6(1):e2251833. PubMed ID: 36662525
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
17. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccination during pregnancy: coverage and safety.
Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
[TBL] [Abstract][Full Text] [Related]
20. Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS).
Haidar G; Agha M; Bilderback A; Lukanski A; Linstrum K; Troyan R; Rothenberger S; McMahon DK; Crandall MD; Sobolewksi MD; Nathan Enick P; Jacobs JL; Collins K; Klamar-Blain C; Macatangay BJC; Parikh UM; Heaps A; Coughenour L; Schwartz MB; Dueker JM; Silveira FP; Keebler ME; Humar A; Luketich JD; Morrell MR; Pilewski JM; McDyer JF; Pappu B; Ferris RL; Marks SM; Mahon J; Mulvey K; Hariharan S; Updike GM; Brock L; Edwards R; Beigi RH; Kip PL; Wells A; Minnier T; Angus DC; Mellors JW
Clin Infect Dis; 2022 Aug; 75(1):e630-e644. PubMed ID: 35179197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
